Welcome to our dedicated page for Retractable Tech SEC filings (Ticker: RVP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Retractable Technologies, Inc. filings document the regulatory record for a Texas medical device manufacturer whose common stock trades on NYSE American under RVP. Recent Form 8-K reports cover material events such as operating-results releases, workforce reductions, product designation announcements, and dividends on Series II and Series III Class B Convertible Preferred Stock.
The company’s proxy materials disclose annual meeting matters, director elections, board structure, shareholder voting procedures, and executive-governance information. Together, the filings describe Retractable’s public-company capital structure, recurring event disclosures, governance processes, and formal exhibits tied to its safety medical products business.
Retractable Technologies, Inc. filed an Form 8-K dated August 14, 2025 disclosing an Item 8.01 other event and Item 9.01 exhibits. The filing attaches a press release that announces results for the periods ended June 30, 2025. The document is signed by John W. Fort III, Vice President, Chief Financial Officer, and Chief Accounting Officer, and lists Little Elm, Texas as the company's principal executive office.
Retractable Technologies, Inc. (RVP) reported net sales of $10.45 million for the quarter and $18.74 million for the first six months of 2025, up from $6.03 million and $13.63 million a year earlier. Unit growth was driven by higher EasyPoint® needle volumes, but average selling prices fell due to product mix and distributor transaction fees, producing a small quarterly gross loss of $0.11 million and a six-month gross loss of $0.42 million.
The company recorded a six-month net loss of $10.59 million versus $13.74 million a year earlier. Investment holdings were $30.0 million at fair value (down from $40.3 million), producing a $5.6 million unrealized investment loss YTD. Cash totaled $3.04 million and inventories were $20.45 million. Other long-term liabilities under the Technology Investment Agreement (TIA) were $60.92 million. Tariffs from Chinese imports materially increased costs—approximately $2.1 million YTD—with second-quarter tariff expense of $561 thousand. The company received $1.9 million in litigation settlement proceeds and sold $5.0 million of securities to support operations.
Thomas J. Shaw, President & CEO and director of Retractable Technologies, Inc. (RVP), acquired 3,983 shares of the issuer's common stock at a weighted average price of $0.8015 under a Rule 10b5-1 plan. After the reported purchase, Mr. Shaw directly beneficially owned 15,593,248 shares and held indirect beneficial ownership of 831,600 shares through arrangements that include trustee investment power and a voting agreement.
The filing identifies Mr. Shaw as a director, officer and a greater-than-10% owner and states the 10b5-1 plan was adopted on August 22, 2024. The disclosed transaction was reported on Form 4 and was filed by one reporting person.
Thomas J. Shaw, identified as President & CEO, Director and a 10% owner of Retractable Technologies, Inc. (RVP), reported a transaction executed under a Rule 10b5-1 plan. On 08/12/2025 he acquired 8,411 shares of common stock at a weighted-average price of $0.823. Following the reported transaction, he is shown as directly beneficially owning 15,589,265 shares.
In addition to direct holdings, the filing discloses 831,600 shares of indirect beneficial ownership described as voting or investment control; the filing notes Mr. Shaw has investment power over 500,000 shares as trustee for a family member and voting control over the remainder pursuant to a voting agreement. The 10b5-1 plan was adopted on 08/22/2024, indicating the trade was part of a pre-arranged program rather than an ad hoc transaction.
Thomas J. Shaw, President & CEO, Director and 10% owner of Retractable Technologies (RVP), reported an acquisition of 2,100 common shares on 08/11/2025 under a Rule 10b5-1 plan at a weighted average price of $0.8118. After this transaction he beneficially owns 15,580,854 shares directly and 831,600 shares indirectly. The filing explains the indirect holdings include investment power over 500,000 shares as Trustee and voting control over the remainder pursuant to a voting agreement. The Rule 10b5-1 plan was adopted on August 22, 2024.
Thomas J. Shaw, President, CEO, Director and reported 10% owner of Retractable Technologies, Inc. (RVP), reported a transaction dated 08/07/2025 showing an acquisition of 49,541 shares of common stock at a weighted average price of $0.747. Following the reported transaction, the filing lists 15,578,754 shares beneficially owned directly and 831,600 shares beneficially owned indirectly.
The filing explains Mr. Shaw has investment power over 500,000 shares as trustee for a family member and retains voting control over the remainder under a voting agreement. The remarks note a Rule 10b5-1 plan adoption date of August 22, 2024. The form is signed by an attorney-in-fact on 08/11/2025.
Retractable Technologies (RVP) filed a Form 4 showing that President, CEO, Director and 10% owner Thomas J. Shaw bought 1,575 common shares on 08/01/2025 at a weighted-average price of $0.703. The transaction was coded “P” (open-market purchase) and executed under a Rule 10b5-1 plan adopted 08/22/2024.
Following the purchase, Shaw directly owns 15,498,332 shares and holds indirect control over an additional 831,600 shares—bringing his total beneficial interest to roughly 16.3 million shares. The incremental buy represents less than 0.01% of his existing stake, so economic impact is minimal, yet the action reiterates insider alignment at a depressed price level. No derivative security activity was reported.